title: Chemogenomic analysis of G-protein coupled receptors and their ligands deciphers locks and keys governing diverse aspects of signalling.
abstract: Understanding the molecular mechanism of signalling in the important super-family of G-protein-coupled receptors (GPCRs) is causally related to questions of how and where these receptors can be activated or inhibited. In this context, it is of great interest to unravel the common molecular features of GPCRs as well as those related to an active or inactive state or to subtype specific G-protein coupling. In our underlying chemogenomics study, we analyse for the first time the statistical link between the properties of G-protein-coupled receptors and GPCR ligands. The technique of mutual information (MI) is able to reveal statistical inter-dependence between variations in amino acid residues on the one hand and variations in ligand molecular descriptors on the other. Although this MI analysis uses novel information that differs from the results of known site-directed mutagenesis studies or published GPCR crystal structures, the method is capable of identifying the well-known common ligand binding region of GPCRs between the upper part of the seven transmembrane helices and the second extracellular loop. The analysis shows amino acid positions that are sensitive to either stimulating (agonistic) or inhibitory (antagonistic) ligand effects or both. It appears that amino acid positions for antagonistic and agonistic effects are both concentrated around the extracellular region, but selective agonistic effects are cumulated between transmembrane helices (TMHs) 2, 3, and ECL2, while selective residues for antagonistic effects are located at the top of helices 5 and 6. Above all, the MI analysis provides detailed indications about amino acids located in the transmembrane region of these receptors that determine G-protein signalling pathway preferences.
authors.affiliation: Leibniz-Institut für Molekulare Pharmakologie, Berlin, Germany.
authors.forename: Jörg D
authors.initials: JD
authors.lastname: Wichard
authors.forename: Antonius
authors.initials: A
authors.lastname: Ter Laak
authors.forename: Gerd
authors.initials: G
authors.lastname: Krause
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Heinrich
authors.forename: Ronald
authors.initials: R
authors.lastname: Kühne
authors.forename: Gunnar
authors.initials: G
authors.lastname: Kleinau
mesh_terms: D000465:Algorithms; D000595:Amino Acid Sequence / Q000235:genetics / Q000502:physiology; D018360:Crystallography, X-Ray; D006801:Humans; D008024:Ligands; D008954:Models, Biological; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010597:Pharmacogenetics / Q000379:methods; D011485:Protein Binding / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D054730:Protein Interaction Domains and Motifs / Q000235:genetics / Q000502:physiology; D025941:Protein Interaction Mapping; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics*; D020539:Sequence Analysis, Protein; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics* / Q000502:physiology
chemical_list: D008024:Ligands; D043562:Receptors, G-Protein-Coupled